Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis
Individual results vary, but clinical studies have shown: Semaglutide : Patients may lose an average of 10% to 15% of their body weight over a 68-week period
36,37 In two of the aforementioned trials, researchers reported changes in each of the 11 symptoms on the MRS: women taking the Siberian rhubarb extract in these trials experienced significant reductions in all 11 items on the MRS after 12 weeks compared with those taking placebo.35,36 In a follow-up study, 80 of the initial 109 participants were given the same dose of the extract for 48 weeks of observation, and 51 continued treatment for an additional 48 weeks
For simplicity, Table 2 shows whether there is ANY coverage of Wegovy for obesity in these market segments
Lucie Jette et al, hGRF1-29-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long Lasting GRF Analog, ResearchGate, January 2005
GLP-1 medications address weight from a different angle (appetite and insulin), while thyroid hormones address it through cellular energy expenditure